Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin vs Saline for Sepsis-Induced Hypotension in Cirrhosis
NCT02462902Phase 4Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in septic shock (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Total number of patients with Mean Arterial Pressure (MAP) ≥ 65 mmHg at 3 hours. Started Feb 2014; status: completed.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02462902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462902.